Trulieve Cannabis is trading 11.36% down at $11.00 in pre-market after a DEA judge paused the remaining marijuana-rescheduling case, delaying a recommendation investors viewed as a near-term catalyst.
- The September 29 order pauses consideration while the judge weighs a request to reopen the record; it does not reject rescheduling.
- The report linked the pause to after-hours weakness in cannabis stocks.
- Trulieve traded as low as about $11 in extended hours.